Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page
- Check3 days agoChange Detected- The page's revision label updated from v3.6.0 to v3.6.2 in the record history. This change indicates a newer version of the page's history UI and does not alter the study data, eligibility, status, or presented content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRecruitment status updated to 'no longer looking for participants', indicating that the study is not enrolling currently. The record now shows Revision: v3.6.0, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page's footer revision tag was updated from v3.5.4 to v3.5.5. This reflects a new release of the page's content without altering study data or core functionality.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.5.4 was added to the record history, replacing the previous v3.5.3 entry and indicating a minor update in the page's version history.SummaryDifference0.1%

- Check60 days agoChange DetectedNew content sections Adverse Events and Outcome Measures (Results) were added to the study record history. The history also shows a Returned date of 2026-04-24 and a new Revision (v3.5.3) with QC status Has Not Concluded, replacing the prior Revision v3.5.2.SummaryDifference0.5%

- Check75 days agoChange DetectedRevision history shows the addition of v3.5.2 and removal of v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.